STAA STAAR SURGICAL COcompanySEC Filings & Insider Trading Activity 2026
Latest STAAR SURGICAL CO (STAA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on April 8, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for STAAR SURGICAL CO (STAA) (SEC CIK 718937), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2026-01-02)
Business Overview
- • Core business: development and sales of Implantable Collamer Lenses (ICLs) for treatment of myopia and refractive errors
- • New product emphasis: full launch of EVO+ premium larger optic lens in China and planned introduction of additional lens sizes for surgical flexibility
Risk Factors
- • Termination of Alcon Merger Agreement January 2026; $17.1 million Merger transaction costs in fiscal 2025
- • China macroeconomic downturn causing net sales drop from $313.9M in 2024 to $239.4M in 2025, with China distributor sales down from $162.3M to $77.8M
Management Discussion & Analysis
- • No revenue, profitability, segment, cash flow, or forward-looking data disclosed in the MD&A section provided
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year FY2025 results reported (fiscal year ended January 2, 2026)
- • Full financials in Exhibit 99.1 — press release is the primary source for revenue, margins, and guidance
Item 7.01: Regulation FD Disclosure
- • Earnings call scheduled March 3, 2026 at 5:30 p.m. ET covering Q4 and full-year results ended January 2, 2026
- • Dual Interim Co-CEOs presenting — COO and CFO sharing top role signals ongoing leadership transition
Annual Reports Archive10-K
AI-powered analysis of STAAR SURGICAL CO (STAA) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of STAAR SURGICAL CO (STAA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $284.4M | $322.4M | $313.9M | $239.4M |
| Gross Profit | $223.4M | $252.7M | $239.6M | $182.4M |
| Operating Income | — | $28.1M | -$12.6M | -$91.7M |
| Net Income | — | $21.3M | -$20.2M | -$80.4M |
| Gross Margin | 78.5% | 78.4% | 76.3% | 76.2% |
| Op. Margin | — | 8.7% | -4.0% | -38.3% |
| Net Margin | — | 6.6% | -6.4% | -33.6% |
| Balance Sheet | ||||
| Total Assets | — | $488.7M | $509.5M | $451.7M |
| Equity | — | $386.0M | $397.3M | $344.2M |
| ROE | — | 5.5% | -5.1% | -23.4% |
Source: XBRL financial data from STAAR SURGICAL CO (STAA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 8, 2026 | — | — | — |
10-K | Mar 3, 2026 | Jan 2, 2026 | Analysis | |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Feb 5, 2026 | — | — | |
8-K | Feb 2, 2026 | — | — | |
8-K | Jan 16, 2026 | — | — | |
8-K | Jan 15, 2026 | — | — | |
8-K | Jan 6, 2026 | — | — | |
8-K | Jan 6, 2026 | — | — | |
8-K | Dec 9, 2025 | — | — | |
8-K | Dec 8, 2025 | — | — | |
10-Q | Nov 5, 2025 | Sep 26, 2025 | — | |
10-Q | Aug 6, 2025 | Jun 27, 2025 | — | |
10-Q | May 7, 2025 | Mar 28, 2025 | — | |
10-K | Feb 21, 2025 | Dec 27, 2024 | — | |
10-Q | Oct 30, 2024 | Sep 27, 2024 | — | |
10-Q | Aug 7, 2024 | Jun 28, 2024 | — | |
10-Q | May 7, 2024 | Mar 29, 2024 | — | |
10-K | Feb 27, 2024 | Dec 29, 2023 | — | |
10-Q | Nov 6, 2023 | Sep 29, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 3, 2023 | Mar 31, 2023 | — | |
10-K | Feb 23, 2023 | Dec 30, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 10, 2022 | Jul 1, 2022 | — |
Frequently Asked Questions
What are the latest STAA SEC filings in 2026?
STAAR SURGICAL CO (STAA) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on April 8, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did STAA file its most recent 10-K annual report?
STAAR SURGICAL CO (STAA) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view STAA 10-Q quarterly reports?
STAAR SURGICAL CO (STAA)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every STAA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has STAA filed recently?
STAAR SURGICAL CO (STAA)'s most recent 8-K was filed on April 8, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find STAA insider trading activity (Form 4)?
SignalX aggregates every STAA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does STAA file with the SEC?
STAAR SURGICAL CO (STAA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new STAA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for STAAR SURGICAL CO (STAA).
What is STAA's SEC CIK number?
STAAR SURGICAL CO (STAA)'s SEC CIK (Central Index Key) number is 718937. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 718937 to look up all STAA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find STAA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from STAAR SURGICAL CO (STAA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of STAAR SURGICAL CO SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 63+ filings.